Clinical Trial Update: Assessment of CMV-specific ELISPOT Assay for Predicting CMV Infection in Bone Marrow Transplant Recipients (ACE-BMT)

View source ↗

Summary

This document reports an update on a clinical trial evaluating a CMV-specific ELISPOT assay to predict cytomegalovirus infection in patients undergoing bone mar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Snippet

Sponsor: Asan Medical Center | Conditions: Bone Marrow Transplantation | Status: COMPLETED